JP2001504113A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504113A5
JP2001504113A5 JP1998522274A JP52227498A JP2001504113A5 JP 2001504113 A5 JP2001504113 A5 JP 2001504113A5 JP 1998522274 A JP1998522274 A JP 1998522274A JP 52227498 A JP52227498 A JP 52227498A JP 2001504113 A5 JP2001504113 A5 JP 2001504113A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998522274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504113A (ja
Filing date
Publication date
Priority claimed from GBGB9623283.0A external-priority patent/GB9623283D0/en
Priority claimed from GBGB9715893.5A external-priority patent/GB9715893D0/en
Application filed filed Critical
Priority claimed from PCT/GB1997/003033 external-priority patent/WO1998021188A1/en
Publication of JP2001504113A publication Critical patent/JP2001504113A/ja
Publication of JP2001504113A5 publication Critical patent/JP2001504113A5/ja
Ceased legal-status Critical Current

Links

JP52227498A 1996-11-08 1997-11-04 ファクターXaを阻害する複素環式化合物誘導体 Ceased JP2001504113A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9623283.0A GB9623283D0 (en) 1996-11-08 1996-11-08 Heterocyclic derivatives
GB9623283.0 1997-07-29
GBGB9715893.5A GB9715893D0 (en) 1997-07-29 1997-07-29 Heterocyclic derivatives
GB9715893.5 1997-07-29
PCT/GB1997/003033 WO1998021188A1 (en) 1996-11-08 1997-11-04 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa

Publications (2)

Publication Number Publication Date
JP2001504113A JP2001504113A (ja) 2001-03-27
JP2001504113A5 true JP2001504113A5 (enExample) 2006-01-05

Family

ID=26310361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52227498A Ceased JP2001504113A (ja) 1996-11-08 1997-11-04 ファクターXaを阻害する複素環式化合物誘導体

Country Status (28)

Country Link
US (2) US6300330B1 (enExample)
EP (2) EP0937048B1 (enExample)
JP (1) JP2001504113A (enExample)
KR (1) KR20000053128A (enExample)
CN (1) CN1220682C (enExample)
AT (1) ATE258167T1 (enExample)
AU (1) AU731929B2 (enExample)
BG (1) BG64258B1 (enExample)
BR (1) BR9712672A (enExample)
CA (1) CA2266890A1 (enExample)
CZ (1) CZ296342B6 (enExample)
DE (1) DE69727308T2 (enExample)
DK (1) DK0937048T3 (enExample)
ES (1) ES2213208T3 (enExample)
HU (1) HUP0001098A3 (enExample)
IL (1) IL129706A (enExample)
MY (1) MY124122A (enExample)
NO (1) NO312894B1 (enExample)
NZ (1) NZ334710A (enExample)
PL (1) PL189703B1 (enExample)
PT (1) PT937048E (enExample)
RU (2) RU2213732C2 (enExample)
SK (1) SK284665B6 (enExample)
TR (1) TR199901006T2 (enExample)
TW (1) TW458968B (enExample)
UA (1) UA56197C2 (enExample)
WO (1) WO1998021188A1 (enExample)
YU (1) YU20999A (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
AU1608397A (en) 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
ATE242774T1 (de) 1997-02-13 2003-06-15 Astrazeneca Ab Heterozyklische verbindungen die als oxido- squalen-zyklase-inhibitoren anwendung finden
AU5999698A (en) 1997-02-13 1998-09-08 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
DE69835430T2 (de) 1997-05-30 2007-03-08 Takeda Pharmaceutical Co. Ltd. Sulfonamidderivate, ihre herstellung und verwendung
GB9715894D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic derivatives
GB9715895D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
US6525042B1 (en) * 1997-09-30 2003-02-25 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
WO1999037304A1 (en) * 1998-01-27 1999-07-29 Aventis Pharmaceuticals Products Inc. SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
CA2317017A1 (en) 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
GB9809350D0 (en) * 1998-05-02 1998-07-01 Zeneca Ltd Novel salt
GB9809349D0 (en) * 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
ES2232131T3 (es) * 1998-05-02 2005-05-16 Astrazeneca Ab Derivados heterociclicos que inhiben el factor xa.
AU5196399A (en) * 1998-08-11 2000-03-06 Daiichi Pharmaceutical Co., Ltd. Novel sulfonyl derivatives
AU3127900A (en) 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
GB9902989D0 (en) * 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
TW200404789A (en) 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
GB9914342D0 (en) * 1999-06-19 1999-08-18 Zeneca Ltd Compound
EP1188755B1 (en) 1999-06-22 2006-05-03 Takeda Pharmaceutical Company Limited Acylhydrazine derivatives, process for preparing the same and use thereof
GB9917344D0 (en) * 1999-07-24 1999-09-22 Zeneca Ltd Novel salt
WO2001007436A2 (en) * 1999-07-28 2001-02-01 Aventis Pharmaceuticals Inc. Substituted oxoazaheterocyclyl compounds
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
GB0012448D0 (en) 2000-05-24 2000-07-12 Astrazeneca Ab New process
BR0107282A (pt) * 2000-09-29 2004-07-06 Cor Therapeutics Inc Composto, composição farmacêutica e métodos para prevenir ou tratar uma condição em um mamìfero e para inibir a coagulação de amostras biológicas
JP4012064B2 (ja) 2000-11-02 2007-11-21 エフ.ホフマン−ラ ロシュ アーゲー コレステロールを低下させるベンゾ〔b〕チオフェンおよびベンゾ〔d〕イソチアゾール
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
IL156577A0 (en) 2000-12-22 2004-01-04 Axys Pharm Inc Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
WO2003024986A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
RU2004117877A (ru) 2001-11-14 2006-01-10 Авентис Фармасьютикалз Инк. (Us) Олигопептиды и композиции, содержащие их, в качестве ингибиторов катепсина s
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
EP1569912B1 (en) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
CN1703395A (zh) * 2002-08-09 2005-11-30 特兰斯泰克制药公司 芳基和杂芳基化合物以及调节凝血的方法
MXPA05006989A (es) * 2002-12-25 2005-09-22 Daiichi Seiyaku Co Derivados de diamina.
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
US7501538B2 (en) * 2003-08-08 2009-03-10 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
EP1858853A2 (en) * 2005-02-24 2007-11-28 Janssen Pharmaceutica N.V. Novel pyridine derivatives as potassium ion channel openers
WO2007008145A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
JP4987324B2 (ja) * 2006-03-03 2012-07-25 エヌ・イーケムキャット株式会社 炭素−炭素結合の生成方法
GB0813142D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
JP7775080B2 (ja) 2019-07-01 2025-11-25 トニックス ファーマ リミテッド 抗cd154抗体およびその使用
US20240059781A1 (en) 2021-01-06 2024-02-22 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT340933B (de) 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
US4167567A (en) 1978-05-05 1979-09-11 The Upjohn Company Antihypertensive 4-aminoquinolines
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
SE8203887D0 (sv) 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
DE3246932A1 (de) 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
FR2557570B1 (fr) 1984-01-04 1986-04-18 Adir Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4840963A (en) 1984-03-14 1989-06-20 Merck & Co., Inc. 2-Sulfamoyl-1H-indole derivatives for the treatment of elevated intraocular pressure
GB8601160D0 (en) 1986-01-17 1986-02-19 Fujisawa Pharmaceutical Co Heterocyclic compounds
GB8603120D0 (en) 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
SU1486061A3 (ru) * 1987-03-26 1989-06-07 Mitsubishi Chem Ind Способ получения производных пиридазинона или их солей
GB8710494D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Antiarrhythmic agents
JPH0696575B2 (ja) 1987-09-17 1994-11-30 三菱化成株式会社 4−アミノピリジン誘導体及びその酸付加塩
US4871721A (en) 1988-01-11 1989-10-03 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
GB8817315D0 (en) 1988-07-20 1988-08-24 Pfizer Ltd Triazole antifungal agents
GB8819307D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Antiarrhythmic agents
DE3905364A1 (de) 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
IL94805A (en) * 1989-06-28 1994-04-12 Ciba Geigy Ag (Arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids, processfor their preparation and pharmaceutical compositions containing them
IE64358B1 (en) 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
US5032604A (en) 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE3943225A1 (de) 1989-12-23 1991-06-27 Schering Ag Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
KR920703558A (ko) 1990-11-15 1992-12-18 원본미기재 메타-치환 페닐알라닌 유도체
DE4036552C1 (enExample) 1990-11-16 1992-02-06 Boehringer Mannheim Gmbh, 6800 Mannheim, De
EP0495750A3 (en) 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine
IT1245712B (it) 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1993000342A1 (en) 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
JPH06510786A (ja) 1991-09-19 1994-12-01 スミスクライン・ビーチャム・コーポレイション ロイコトリエン関連疾患治療用ピリジン化合物
PH31294A (en) 1992-02-13 1998-07-06 Thomae Gmbh Dr K Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
HU211995B (en) 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
US5371091A (en) 1992-08-31 1994-12-06 Bristol-Myers Squibb Company Heteroaromatic amine thrombin inhibitors
FR2697252B1 (fr) 1992-10-28 1994-12-09 Fournier Ind & Sante Dérivés de 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-triméthyl-(8abeta)-6-isoquinolineamine, leur procédé de préparation et leur utilisation en thérapeutique.
DE4243858A1 (de) 1992-12-23 1994-06-30 Thomae Gmbh Dr K Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5332822A (en) 1992-12-24 1994-07-26 Bristol-Myers Squibb Company Heteroaromatic and thioheteroaromatic substituted sulfonamide thrombin inhibitors
US5364865A (en) 1992-12-30 1994-11-15 Sterling Winthrop Inc. Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
DE4302485A1 (de) 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
AU5878194A (en) 1993-02-10 1994-08-29 Pentapharm Ag Piperazides of substituted phenylalanine derivates as thrombin inhibitors
TW257757B (enExample) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
DE4306506A1 (de) 1993-03-03 1994-09-08 Boehringer Mannheim Gmbh Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE4306873A1 (de) 1993-03-05 1994-09-08 Boehringer Mannheim Gmbh Neue 4-Aminopyridine-Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CA2155307A1 (en) 1993-03-29 1994-10-13 Michael Garth Wayne Heterocyclic compounds as platelet aggregation inhibitors
ATE202345T1 (de) 1993-03-29 2001-07-15 Astrazeneca Ab Heterozyklische derivate als plätchenaggregationsinhibitoren
US5681954A (en) 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
WO1996005189A1 (de) 1994-08-09 1996-02-22 Pentapharm Ag Neue inhibitoren vom benzamidintyp
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
EP0796098A4 (en) 1994-12-22 1998-04-29 Smithkline Beecham Corp FIBRINOGEN RECEPTOR ANTAGONISTS
WO1996019475A1 (en) 1994-12-22 1996-06-27 Smithkline Beecham Corporation Fibrinogen receptor antagonists
DE19504367A1 (de) * 1995-02-10 1996-08-14 Boehringer Mannheim Gmbh Neue Pyridin- bzw. Pyridazinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
IL117149A0 (en) 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5856326A (en) 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL117580A0 (en) 1995-03-29 1996-07-23 Merck & Co Inc Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
IT1282797B1 (it) 1995-04-21 1998-03-31 Colla Paolo Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
GB9516709D0 (en) 1995-08-15 1995-10-18 Zeneca Ltd Medicament
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
AU1608397A (en) 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
GB9602294D0 (en) 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
EP0892780B1 (en) * 1996-02-22 2002-11-20 Bristol-Myers Squibb Pharma Company M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
PL331599A1 (en) 1996-08-14 1999-08-02 Zeneca Ltd Substituted derivatives of pyrimidine and their pharmaceutical application
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні

Similar Documents

Publication Publication Date Title
JP2001508088A5 (enExample)
JP2000510825A5 (enExample)
JP2000512138A5 (enExample)
JP2000507118A5 (enExample)
JP2000514896A5 (enExample)
JP2001503657A5 (enExample)
JP2001502742A5 (enExample)
JP2000511787A5 (enExample)
JP2001507199A5 (enExample)
JP2000509541A5 (enExample)
JP2001500134A5 (enExample)
JP2000513403A5 (enExample)
JP2000508166A5 (enExample)
JP2000511527A5 (enExample)
JP2000509023A5 (enExample)
JP2000513558A5 (enExample)
JP2000508988A5 (enExample)
JP2000513272A5 (enExample)
JP2001502172A5 (enExample)
JP2001500176A5 (enExample)
JP2000515040A5 (enExample)
JP2001504437A5 (enExample)
JP2001504113A5 (enExample)
JP2001502461A5 (enExample)
JP2001503774A5 (enExample)